Severe Burn Clinical Trial
Verified date | December 2017 |
Source | Southeast University, China |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To delineate nutritional support in adults patients with severe burns to investigate associations between nutritional practice and clinical outcomes.
Status | Completed |
Enrollment | 100 |
Est. completion date | October 2, 2014 |
Est. primary completion date | September 24, 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients were at least 18 years of age - Patients were expected to survive more than 48 hours. Exclusion Criteria: - irreversible disease |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Southeast University, China |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mortality at 28 days | Daily data were recorded for a maximum of 28 days per patient. Patients alive in hospital at the 28th day or discharged prior to 28 days were considered to be survivors. | 28days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04264065 -
Albumin and Prognosis of Severely Patients Burns
|
||
Completed |
NCT03335137 -
Determining Drug Levels of Beta-lactam Antibiotics in Severe Burned Patients
|
N/A | |
Completed |
NCT02638779 -
REAnimation Low Immune Status Markers
|
N/A |